We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$158B
AUM Growth
-$60B
Cap. Flow
-$70.1B
Cap. Flow %
-44.4%
Top 10 Hldgs %
24.44%
Holding
5,371
New
314
Increased
1,955
Reduced
1,669
Closed
872

Sector Composition

Rank Sector Weight
1 Technology 28.28%
2 Healthcare 11.27%
3 Financials 10.52%
4 Consumer Discretionary 10.12%
5 Communication Services 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMC icon
3926
TMC The Metals Company
TMC
$1.54B
$23.6K ﹤0.01%
14,492
DWAS icon
3927
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$429M
$23.6K ﹤0.01%
300
SCHA icon
3928
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$23.5K ﹤0.01%
1,072
RDW icon
3929
Redwire
RDW
$2.06B
$23.4K ﹤0.01%
9,183
-947
-9% -$2.58K
VOR icon
3930
Vor Biopharma
VOR
$1.15B
$23.3K ﹤0.01%
+378
New +$34.5K
PLSE icon
3931
Pulse Biosciences
PLSE
$2.43B
$23.3K ﹤0.01%
3,239
+3,050
+1,614% +$19.5K
SLDB icon
3932
Solid Biosciences
SLDB
$794M
$23.1K ﹤0.01%
4,417
CNTG
3933
DELISTED
Centogene N.V. Common Shares
CNTG
$23K ﹤0.01%
15,348
LBPH
3934
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$22.9K ﹤0.01%
+3,124
New +$23.6K
HEWJ icon
3935
iShares Currency Hedged MSCI Japan ETF
HEWJ
$717M
$22.9K ﹤0.01%
+681
New +$21.1K
URG
3936
Ur-Energy
URG
$485M
$22.9K ﹤0.01%
21,782
-106,318
-83% -$102K
HELP
3937
Cybin Inc
HELP
$485M
$22.8K ﹤0.01%
1,584
AEAE
3938
DELISTED
AltEnergy Acquisition Corp
AEAE
$22.4K ﹤0.01%
2,166
-88,777
-98% -$918K
BIOR
3939
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$22.3K ﹤0.01%
580
CBUS icon
3940
Cibus
CBUS
$147M
$22.3K ﹤0.01%
+2,120
New +$38.1K
CPSS icon
3941
Consumer Portfolio Services
CPSS
$202M
$22.2K ﹤0.01%
1,903
-2,737
-59% -$29.6K
WHWK
3942
Whitehawk Therapeutics
WHWK
$190M
$22.1K ﹤0.01%
3,228
-4,088
-56% -$31.8K
NVCT icon
3943
Nuvectis Pharma
NVCT
$678M
$21.9K ﹤0.01%
+1,371
New +$21.9K
OBIO icon
3944
Orchestra BioMed
OBIO
$238M
$21.9K ﹤0.01%
3,125
-3,829
-55% -$58.1K
VAXX
3945
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$21.8K ﹤0.01%
+8,631
New +$18.3K
XAIR icon
3946
Beyond Air
XAIR
$3.8M
$21.7K ﹤0.01%
13
-59
-82% -$135K
TRML
3947
DELISTED
Tourmaline Bio
TRML
$21.4K ﹤0.01%
705
-1,171
-62% -$29.9K
GIL icon
3948
Gildan
GIL
$10.3B
$21.4K ﹤0.01%
664
-8,961
-93% -$275K
GYRE icon
3949
Gyre Therapeutics
GYRE
$641M
$21.2K ﹤0.01%
4,014
PBFS icon
3950
Pioneer Bancorp
PBFS
$432M
$21.2K ﹤0.01%
2,364
-3,538
-60% -$31K

Similar funds

Barclays's Q2 2023 Portfolio in Review

As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.

  • Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
  • Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
  • Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
  • Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
  • Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
  • Barclays opened 314 new positions and closed 872 in Q2 2023.
  • Barclays's portfolio value fell 28% quarter-over-quarter to $158B.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.